Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
588 Leser
Artikel bewerten:
(1)

Lassen Law: COVID-19 Skyrockets Denied Life Insurance Claims; Life Insurance Attorney Christian Lassen Explains What You Can Do

Finanznachrichten News

PHILADELPHIA, PA / ACCESSWIRE / December 10, 2020 / As cases of COVID-19-related deaths continue to rise, the number of denied life insurance claims related to the pandemic also appears to be keeping pace. From California to New York, Florida to Alaska, many people are finding that the insurance companies they and their families have paid for peace of mind are leaving them holding the bill--and in some cases even delivering false information regarding state appeal laws.

While the pandemic -and related health issues that can cause a more severe reaction after contracting Coronavirus- has created an unprecedented strain on the insurance industry, many individuals are being sent denial letters, effectively claiming in some cases that state insurance law prohibits the ability to appeal a claim denial. Typically, this claim is patently false, according to life insurance attorney Christian Lassen of Lassen Law, and consumers should always consult a qualified life insurance attorney before accepting this as fact.

"Some companies are brazenly claiming that COVID-19 was not a known risk that they insured. Most are denying the policies based on a misrepresentation regarding health history on the underlying applications. For example, they may find a minor emergency room visit and say that wasn't disclosed on the application. Our firm sends out a 200-page legal brief which bypasses the claims adjuster and goes straight to the in-house legal department, and all our claims are approved", Christian explains. Should one forget to include a minor Emergency Room trip or visit to the local Urgent Care on their application, this could result in claim denial.

However, not everything is as it seems- and there is hope.

The life insurance attorneys at lassenlaw.com are helping to bring clarity to the often misleading information surrounding COVID-related life insurance claim denials. They help thousands combat denied life insurance claims and are willing to work around the clock to make sure claimants get the care and coverage you deserve. Well-versed within a variety of disciplines, the life insurance attorneys at Lassen Law are ready, willing, and able to stand up on your behalf.

Utilizing a tried-and-tested method involving over 200 pages of legal documents, Christian Lassen and his associates cut out the claims adjustor taking the claim straight to the in-house legal department- thus helping to get claims approved quickly.

No longer do you have to worry about braving the storms of paperwork and red tape on your own, or fielding false claims indicating no appeal is possible. As trusted members of the local community and consummate professionals in their field of expertise, personal life insurance attorneys are prepared to get you the help you need in these trying times.

In a time of mixed information, confusing rhetoric, and changing legislation; it's never been more important to seek expert legal advice regarding your denied life insurance claim.

Consultations are free and can be easily obtained by visiting lassenlaw.com or calling (800) 900-2521.

SOURCE: Lassen Law



View source version on accesswire.com:
https://www.accesswire.com/620444/COVID-19-Skyrockets-Denied-Life-Insurance-Claims-Life-Insurance-Attorney-Christian-Lassen-Explains-What-You-Can-Do

© 2020 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.